Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Dec 6, 2019 11:20 AM ET

Lung Cancer Therapeutics Market rise exponentially and anticipated to rise at 13.0% CAGR and reach a valuation of US$ 48,725.9 Mn by 2026


Lung Cancer Therapeutics Market rise exponentially and anticipated to rise at 13.0% CAGR and reach a valuation of US$ 48,725.9 Mn by 2026

iCrowd Newswire - Dec 6, 2019

The targeted segment is forecast to emerge dominant among various therapies in The Global Lung Cancer Therapeutics Market, finds Fortune Business Insights in a new study. The study is titled “Lung Cancer Therapeutics Market: Global Market Analysis, Insights, and Forecasts, 2018 2026.” According to the study, the global lung cancer therapeutics market will exhibit an exponential CAGR of 13.0% to reach a value of US$ 48,725.9 Mn by 2026 from US$ 18,327.6 Mn in 2018.

Lung cancer is considered one of the leading causes of death by cancer. Cancer can be a result of continuous exposure to asbestos, and unhealthy lifestyle that includes habits such as pipe smoking, cigarette smoking, cigar smoking. The rising incidence of lung cancer is subsequently fuelling demand for various therapies in the global lung cancer therapeutics market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/lung-cancer-therapeutics-market-100473

Key companies covered in the Lung Cancer Therapeutics Market Research report include

Highlights of the Report

The Asia Pacific to Emerge as the Fastest Growing Region with Rising in Cancer Awareness Programs

North America is expected to dominate the global market for lung cancer therapeutics. In 2018 the region generated a revenue of US$ 8,093.2 Mn. Growth in this region is attributable to the rising prevalence and diagnostics of lung cancer and the increasing adoption of advanced lung cancer therapeutics. Besides this, increasing awareness about cancer is enabling the market in Asia Pacific exhibit a faster CAGR.

A few novel therapeutics are introduced in the market, impelling leading players to research on improved medication. For instance, Genentech, a company operating in the lung cancer therapeutics market has recently launched their new drug named, Alecensa (alectinib), in order to treat ALK-positive non-small cell lung cancer. Such strategies adopted by players will bode well for the global lung cancer therapeutics market in the long run.

Request a Sample Copy of the Global Lung Cancer Therapeutics Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/lung-cancer-therapeutics-market-100473

Global Lung Cancer Therapeutics Market Segmentation

By Therapy

By Cancer Type

By Distribution Channel

More Trending Topics From Fortune Business Insights:

HIV Drugs Market Size, Share and Global Industry Outlook 2025

Cardiac Pacemaker Market Size, Share and Growth Forecast 2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]

Website: Fortune Business Insights

Follow us on:

LinkedIn | Twitter | Blogs

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Lung Cancer Therapeutics Market rise exponentially and anticipated to rise at 13.0% CAGR and reach a valuation of US$ 48,725.9 Mn by 2026






iCrowdNewswire




Tags:    Wire, Research Newswire, English